The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Fried, Frank, Harris, Shriver & Jacobson LLP

Work +1 212 859 8000
Fax +1 212 859 4000
Frankfurt, London, New York, Washington DC

Samuel Groner

Work 212 859 8565
Fried, Frank, Harris, Shriver & Jacobson LLP

Work Department

Litigation, Securities and Shareholder Litigation, M&A Litigation, Commercial Litigation, White Collar Defense, Regulatory Enforcement & Investigations


Mr. Groner is a litigation partner who represents financial institutions and corporations at both the trial and appellate levels in cases involving a broad array of corporate disputes, with an emphasis on securities and shareholder litigation. In the securities arena, Mr. Groner has defended numerous high-profile corporations in the banking, apparel, and pharmaceuticals sectors. He has also represented individuals and entities in connection with United States Attorney's Office and SEC investigations, including insider trading investigations.


Prior to joining Fried Frank, Mr. Groner served as a law clerk to the Hon. Richard J. Cardamone on the United States Court of Appeals for the Second Circuit from 2006 to 2007.


American Bar Association’s Securities Litigation Committee; Federal Bar Council’s Second Circuit Courts Committee; New York City Bar Association


Mr. Groner received his JD from Cornell Law School in 2006 (magna cum laude, Order of the Coif, and Articles Editor of the Cornell Law Review) and his BA from Columbia University in 2003 (cum laude and Phi Beta Kappa).

United States: Dispute resolution

Securities litigation - defense

Within: Securities litigation - defense

Fried, Frank, Harris, Shriver & Jacobson LLP has a busy securities litigation practice in New York and Washington DC, and last year it handled litigation matters for some of the firm's largest corporate clients, including UnderArmour, Perrigo and Xerox. For UnderArmour, James Wareham in DC and Samuel Groner in New York secured the dismissal of a consolidated class action in which it was claimed that its officers made material misstatements regarding the company’s performance and future prospects, including allegations that it had failed to report declining consumer demand for its products. For pharmaceuticals company Perrigo, Wareham and DC-based James Anklam defended a 10b5 class action in which plaintiffs allege that the company's stock price fell due to, inter alia, overstatement of organic growth in the company and failure to disclose problems with the integration of Omega Pharma Invest. Other recommended partners in New York include Stephen JurisIsrael David and Scott Luftglass.

[back to top]

Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to